Merck | MRK - Selling And Administration Expenses


Merck reported EUR1.52B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Adidas EUR 2.68B 283M Mar/2026
Adyen EUR 156.16M 14.47M Dec/2025
Akzo Nobel EUR 804M 7M Mar/2026
Alcon AG USD 882M 19M Mar/2026
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 18.97M 1.03M Dec/2025
AstraZeneca USD 5.06B 455M Mar/2026
BASF EUR 2.13B 84M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Beiersdorf EUR 271M 51M Dec/2025
Covestro EUR 445M 8M Dec/2025
Danone EUR 4.7B 170M Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 749M 36M Mar/2026
Genmab DKK 208M 60M Dec/2025
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.12B 558M Mar/2026
GRIFOLS EUR 281M 5.7M Mar/2026
Henkel EUR 3.49B 38M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Infineon EUR 379M 30M Mar/2026
Lakefront Biotherapeutics EUR 35.5M 8.91M Mar/2026
Linde USD 893M 13M Mar/2026
Merck EUR 1.52B 80M Mar/2026
Novartis USD 3.14B 296M Mar/2026
Philips EUR 1.18B 121M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
UCB EUR 1.47B 193M Dec/2025